These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 820015)

  • 21. Clinical and quantitative electroencephalographical effects of MK 940.
    Gannon P; Itil T; Keskiner A; Hsu B
    Arzneimittelforschung; 1970 Jul; 20(7):971-4. PubMed ID: 4918922
    [No Abstract]   [Full Text] [Related]  

  • 22. Chronic anxiety: deciding the length of treatment.
    Gorman JM; Papp LA
    J Clin Psychiatry; 1990 Jan; 51 Suppl():11-5. PubMed ID: 1967247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of comorbid anxiety and depression.
    Zajecka JM; Ross JS
    J Clin Psychiatry; 1995; 56 Suppl 2():10-3. PubMed ID: 7844101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of social phobia with benzodiazepines.
    Davidson JR; Tupler LA; Potts NL
    J Clin Psychiatry; 1994 Jun; 55 Suppl():28-32. PubMed ID: 8077166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preliminary therapeutic results with a new derivative of benzodiazepine: Oxazepam (Rav. 3031)].
    Maccagnani G; Ferri G; Albonetti G
    Riv Sper Freniatr Med Leg Alien Ment; 1967 Oct; 91(5):1215-41. PubMed ID: 5608976
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapy of psycho-autonomic and dysphoric syndromes in the general practice].
    Maiss HJ
    Med Klin; 1968 May; 63(18):727-30. PubMed ID: 5719912
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experience with Luvatren in ambulatory psychiatric patients].
    Reiter PJ
    Schweiz Arch Neurol Neurochir Psychiatr; 1969; 104(1):169-78. PubMed ID: 5801171
    [No Abstract]   [Full Text] [Related]  

  • 28. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
    Rizley R; Kahn RJ; McNair DM; Frankenthaler LM
    Psychopharmacol Bull; 1986; 22(1):167-72. PubMed ID: 2873609
    [No Abstract]   [Full Text] [Related]  

  • 29. [Preliminary clinical trials of Agr 1240].
    Muyard JP
    Agressologie; 1972; 13(5):337-52. PubMed ID: 4653536
    [No Abstract]   [Full Text] [Related]  

  • 30. The general practitioner's role in the management of psychiatric illness.
    Ress WL
    J Int Med Res; 1977; 5(1 Suppl):126-31. PubMed ID: 863082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term fluoxetine treatment of a large number of obsessive-compulsive patients.
    Levine R; Hoffman JS; Knepple ED; Kenin M
    J Clin Psychopharmacol; 1989 Aug; 9(4):281-3. PubMed ID: 2504781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anxiety in phobic and obsessive patients (author's transl)].
    Pelicier Y
    Nouv Presse Med; 1982 May; 11(22):1674-6. PubMed ID: 7099947
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of chlormezanone on anxiety and tension: a double blind study.
    Friedman D; Moskowitz MD; Rosen M; Rossman M; Sheppard C; Merlis S
    Curr Ther Res Clin Exp; 1966 Jan; 8(1):7-11. PubMed ID: 4955147
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical pharmacology of monoamine oxidase inhibitors.
    McDaniel KD
    Clin Neuropharmacol; 1986; 9(3):207-34. PubMed ID: 3521845
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical and therapeutic considerations on the use of a benzodiazepine derivative, bromazepam (Ro 5-3350) in the treatment of obsessive-phobic disorders].
    Salmoni G; Amati A; Giambelluca A; Vacca L
    Acta Neurol (Napoli); 1973; 28(5):588-609. PubMed ID: 4789497
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of the anti-anxiety activity of lorazepam in ambulatory patients].
    Terra SO; Bueno JR; Pires LL
    J Bras Psiquiatr; 1971; 20(3):237-47. PubMed ID: 4950635
    [No Abstract]   [Full Text] [Related]  

  • 37. Anxiety associated with comorbid depression.
    Möller HJ
    J Clin Psychiatry; 2002; 63 Suppl 14():22-6. PubMed ID: 12562115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoamine oxidase inhibitors in obsessive-compulsive disorder.
    Jenike MA; Surman OS; Cassem NH; Zusky P; Anderson WH
    J Clin Psychiatry; 1983 Apr; 44(4):131-2. PubMed ID: 6833198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychocutaneous drug therapy.
    Lee CS; Koo J
    Semin Cutan Med Surg; 2003 Sep; 22(3):222-33. PubMed ID: 14649589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical experience with a new minor tranquilizer, CS-370].
    Takaishi N; Minami S; Hino K; Kaneko J
    No To Shinkei; 1972 Feb; 24(2):237-42. PubMed ID: 5066941
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.